Patient-derived iPSCs reveal a lasting cellular memory of progeria. In Wiedemann–Rautenstrauch syndrome, differentiation exposed early senescence, genome instability and telomere shortening.
@SpringerNature
pubmed.ncbi.nlm.nih.gov/4292…
#LPoM #lipodystrophy
18
Caveolae are more than membrane dimples. This review explains how caveolin and cavin mutations disrupt lipid handling, signalling and membrane mechanics—linking them to lipodystrophy.
@physiolrev
pubmed.ncbi.nlm.nih.gov/4293…
#LPoM #lipodystrophy
8
Can DXA sharpen the differential diagnosis of FPLD? Regional fat-distribution indices separated FPLD, lipoedema and obesity in women—useful objective phenotyping, not stand-alone diagnosis.
@SpringerNature
pubmed.ncbi.nlm.nih.gov/4295…
#LPoM #lipodystrophy
17
A monoallelic TRIM28 variant may define a new interferonopathy. This family showed chilblains, ulcers, calcinosis and lipodystrophy, with high IFN signalling and partial response to baricitinib.
@BMC_series
pubmed.ncbi.nlm.nih.gov/4290…
#LPoM #lipodystrophy
13
An unusual neonatal clue to CGL1: transient immature brown-fat masses. Severe hypertriglyceridaemia led to AGPAT2 diagnosis before the full lipodystrophy phenotype emerged.
@KargerPublisher
pubmed.ncbi.nlm.nih.gov/4291…
#LPoM #lipodystrophy
1
12
Could one injection replace daily leptin? In a CGL mouse model, AAV-leptin—but not AAV-adiponectin—improved steatosis and hyperinsulinaemia, supporting durable gene-based hormone delivery.
@NaturePortfolio
pubmed.ncbi.nlm.nih.gov/4291…
#LPoM #lipodystrophy
14
Which mouse model fits the question? This review maps models—from LmnaG609G to natural ageing—to the mechanisms they can reveal. @ISOAD2018
pubmed.ncbi.nlm.nih.gov/4285…
#LPoM #lipodystrophy
4
Patient advocacy is part of the science. AIProSaB connects progeria families, research and therapeutic progress around LMNA/progerin biology. @FEBS_Letters
pubmed.ncbi.nlm.nih.gov/4286…
#LPoM #lipodystrophy
9
Metreleptin may do more than improve glycaemia in Werner syndrome: this case also reports improved hepatic steatosis in partial lipodystrophy. @jstage_ej
pubmed.ncbi.nlm.nih.gov/4287…
#LPoM #lipodystrophy
MDPL can mimic Werner syndrome—but the skin can help distinguish them. This case highlights POLD1-related lipodystrophy, telangiectasias and soft-tissue calcification. @WileyGlobal
pubmed.ncbi.nlm.nih.gov/4288…
#LPoM #lipodystrophy
9
Can progerin-driven ageing be switched on at will? New inducible hiPSC lines provide matched LMNA, progerin and GFP controls for precise cellular-ageing models. @ElsevierConnect
pubmed.ncbi.nlm.nih.gov/4286…
#LPoM #lipodystrophy
12
El Prof. David Araújo-Vilar presenta el consenso de ECLip para una nueva definición y categorización de las lipodistrofias: un paso hacia un lenguaje común. @eclipconsortium #SimposioLipodistrofias2026
La Dra. Julia von Schnürbein actualiza el Registro ECLip, una herramienta esencial para generar conocimiento colaborativo sobre lipodistrofias. @eclipconsortium #SimposioLipodistrofias2026 #Investigación
👏👏👏
Éxito del XIV Simposio Internacional de Lipodistrofias. Gracias a los ponentes, pacientes, familias, entidades colaboradoras y asistentes. Nos vemos el próximo año! @AELIP_ @eclipconsortium #SimposioLipodistrofias2026
12
Werner syndrome puts genome maintenance center stage: this review links WRN dysfunction, replication stress, telomere crises and cellular senescence in progeroid aging.
pubmed.ncbi.nlm.nih.gov/4097…
#LPoM #lipodystrophy
@ResearchKarger
Progerin distorted dermal fibroblast nuclei in vivo, yet limited expression did not impair wound healing or hair regrowth — refining how we model progeria pathology.
pubmed.ncbi.nlm.nih.gov/4282…
#LPoM #lipodystrophy
@ElsevierConnect
13
Why does skin fibrosis erase fat? Wnt-driven oxidative stress and lipid peroxidation caused dermal lipodystrophy in vivo; scavengers protected both fat and collagen architecture.
pubmed.ncbi.nlm.nih.gov/4283…
#LPoM #lipodystrophy
@FEBSnews
14
A newborn with mandibuloacral dysplasia type B carried novel compound-heterozygous ZMPSTE24 variants—expanding the genetic and clinical map of this rare lipodystrophy.
pubmed.ncbi.nlm.nih.gov/4283…
#LPoM #lipodystrophy
@FrontiersIn
1
4
Liraglutide in congenital generalized lipodystrophy: a small series found lower HbA1c and insulin needs after 12 weeks, but GI intolerance limited treatment.
pubmed.ncbi.nlm.nih.gov/4284…
#LPoM #lipodystrophy
@FrontiersIn
11
Tirzepatide in partial lipodystrophy: this retrospective series found improvements in weight, HbA1c, triglycerides and insulin needs. A promising signal needing prospective confirmation.
pubmed.ncbi.nlm.nih.gov/4186…
#LPoM #lipodystrophy
@JCEMed





